The interaction between vitamin K nutriture and warfarin administration in patients with bacterial overgrowth due to atrophic gastritis.
Atrophic gastritis patients have intestinal bacterial overgrowth which could produce menaquinones. The aim of this study was to evaluate the interaction between a diet low in phylloquinone and minidoses of warfarin in subjects with and without bacterial overgrowth. Subjects with atrophic gastritis (indicated by serum pepsinogen ratio) and healthy volunteers were studied while fed a restrictive phylloquinone diet and while receiving a minidose of warfarin. Coagulation times, serum osteocalcin, serum undercarboxylated osteocalcin, plasma phylloquinone, plasma K-epoxide, plasma undercarboxylated prothrombin (PIVKA)-II and urinary gamma-carboxyglutamic acid (Gla) were measured. At baseline, there were no differences between groups for any variable measured. Comparisons between baseline and post intervention in both groups, showed significant increases in circulating levels of K-epoxide, PIVKA II and undercarboxylated osteocalcin. However, no differences were observed when comparisons were made between groups. Our data do not support the hypothesis that bacterial synthesis of menaquinones in patients with bacterial overgrowth due to atrophic gastritis confers considerable resistance to the effect of warfarin.
Camilo
M E
ME
Jean Mayer, United States Department of Agriculture, Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA.
Paiva
S A
SA
O'Brien
M E
ME
Booth
S L
SL
Davidson
K W
KW
Sokoll
L J
LJ
Sadowski
J A
JA
Russell
R M
RM
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage*; D001421:Bacteria, Anaerobic / Q000187:drug effects* / Q000254:growth & development; D004032:Diet; D005260:Female; D018565:Food-Drug Interactions; D005757:Gastritis, Atrophic / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007422:Intestines / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D014812:Vitamin K / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D010837:Vitamin K 1 / Q000008:administration & dosage / Q000172:deficiency; D014813:Vitamin K Deficiency / Q000139:chemically induced; D014859:Warfarin / Q000008:administration & dosage*
D000925:Anticoagulants; D014812:Vitamin K; D014859:Warfarin; D010837:Vitamin K 1